The Indian Council of Medical Research (ICMR) has launched a syndromic surveillance initiative for infectious diseases, designed to provide early warnings of outbreaks, according to people familiar with the matter. The network, under the department of health research's Virus Research and Diagnostic Laboratories (VRDL) scheme, will span 70 VRDLs and Infectious Disease Research & Diagnostic Laboratories (IRDLs). It aims to use real-time or near real-time health data to enable immediate analysis and feedback for epidemiological investigation of potential outbreaks, and to help determine the size, spread and speed of an outbreak once detected.
A document outlining the process notes that laboratory testing algorithms for infectious diseases in India currently vary by institute or region and are largely directed at individual diseases with sequential testing, with limited scientific literature on countrywide pathogen prevalence and trends to guide India-specific surveillance and testing policies. It adds that pathogen testing in clinical microbiology laboratories differs according to institutional requirements and available resources, often missing common or critical pathogens and hampering patient care while aggravating public health problems such as antimicrobial resistance. To address this, the ICMR has listed important pathogens causing critical infectious syndromes in India to guide patient management, public health policies and biomedical research.
The priority pathogen lists were developed in consultation with clinicians, laboratory experts and epidemiologists from across the country over a series of 44 meetings, with expert working groups reviewing literature from India and similar settings and drawing on their experience. The lists cover pathogens causing Acute Febrile Illness (including Acute Undifferentiated Fever, Fever with Rash and Fever with Lymphadenopathy), Acute Encephalitis Syndrome, Acute Respiratory Illness and Acute Diarrhoeal Disease, and are intended to guide practitioners, laboratory experts, epidemiologists and policymakers on diagnostic and surveillance approaches. They are also meant to help domestic industry partners develop customised, India-specific and cost-effective medical countermeasures.
The pathogens are listed in a graded manner, from commonly encountered microbes to rare, exotic or high-risk ones. Priority 1A covers commonly detected pathogens crucial to diagnose before treatment begins, while 1B covers other commonly detected pathogens. Priority 2 covers less common pathogens and Priority 3 rare ones that may not be detected in routine settings and may surface during specialised laboratory testing as part of surveillance. The document also sets out screening priorities, including for endemic areas, outbreak-prone and seasonal settings, a subset of test-negative samples, cases with a history of exposure to animals such as cats, rats or rabbits, and exotic pathogens.
